Retrospective study shows 69.4% RSV positivity in hospitalized children under five with LRTI, highlighting vaccine development needs.
Background Respiratory Syncytial Virus (RSV) also known as human Respiratory syncytial viruses (HRSV) are well contagious respiratory pathogens & the leading cause of hospitalization due to Lower Respiratory Tract Infection (LRTI), especially in the pediatric population under 5 years. This study is intended to determine the RSV positivity in LRTI among < 5 year children, admitted at a tertiary care center in 2023. Methods We retrospectively studied the cases with admission diagnosis of LRTI including all acute bronchiolitis from the file record section of the Patan Hospital, a tertiary care center. Both oropharnygeal and nasopharyngeal swabs were sent in all the cases. The swabs were sent to the National Public Health Laboratory were tested for RSV by real-time reverse transcriptase Polymerase Chain Reaction (RT-PCR) using CDC RSV Kit. Although the admissions were about 98, only 1/3rd of the cases were sent for PCV testing due to the limitation of testing in resource limited settings. Results Among the 36 cases, 33% (12/36) were females and 67% (24/36) were males. The sex ratio was 2.0 among the all these cases. Out of the 36 cases sent for the RSV-PCR testing, 69.4% (25/36) were found to be positive for RSV. Out of the 12 female cases, 7 cases were positive among which 2 cases were RSV-B positive. Similarly, out of the total 24 male cases, 18 cases were positive among which 7 cases were RSV-B positive. Interestingly, the entire 36 cases positive for RSV had a median age of 3 years. Conclusion The 69.4% RSV positive cases seen in the admitted LRTI children < 5 years is a sight of a concern. The observed predominance of RSV-B among cases further underscore the necessity for targeted interventions, including improved surveillance and vaccine development for children less than 5 years in resource limited settings in lower and middle incomes countries like Nepal. . Given the resource limitations in PCR testing, future studies should explore cost-effective diagnostic alternatives to ensure timely identification and management of RSV infections in vulnerable pediatric populations. Disclosures All Authors: No reported disclosures
No takes yet. Share an insight, caveat, or question.
Bhandari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: